The Limners and Bards Limited (JMSE:LAB)

Market Cap	1.13B
Revenue (ttm)	972.74M
Net Income (ttm)	54.09M
Shares Out	945.69M
EPS (ttm)	0.06
PE Ratio	21.43
Forward PE	n/a
Dividend	0.03 (2.21%)
Ex-Dividend Date	Sep 26, 2024

Volume	447,774
Average Volume	117,508
Open	1.200
Previous Close	1.200
Day's Range	1.200 - 1.350
52-Week Range	1.010 - 1.980
Beta	0.65
RSI	48.18
Earnings Date	Sep 17, 2025

About Blueprint Medicines

The Limners and Bards Limited, together with its subsidiary, Scope Caribbean Limited, engages in the production, media and content, and advertising agency activities in Jamaica. It operates through Production, Media, and Agency segments. The company offers entertainment services comprising equipment rentals, crew, casting and location scouting, accommodation, animation, motion graphics, art direction, craft services, studio space, and flexible set space; and branding services, including strategy, integrated campaigns, content strategy, design, ...

• Industry: Advertising
• Founded: 2009
• Country: Jamaica
• Stock Exchange: Jamaica Stock Exchange
• Ticker Symbol: LAB

Financial Performance

In 2024, The Limners and Bards's revenue was 958.13 million, a decrease of -14.81% compared to the previous year's 1.12 billion. Earnings were 82.95 million, an increase of 44.72%.